Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Clinical studies confirm that chronic treatment with AOD9604 showed no adverse effect on insulin sensitivity, making it a metabolically selective approach to body composition optimization under medical supervision
C.LiouC
The peptides potential benefits extend to treating inflammatory bowel disease and multiple sclerosis, highlighting its versatility in addressing gastrointestinal and systemic health issues
Jastreboff AM, Kaplan LM, Fras JP
KLOW Blend is a research-grade four-peptide blend supplied in a single co-lyophilized vial BPC-157 (10 mg), GHK-Cu (50 mg), TB-500 (10 mg) and KPV (10 mg), 80 mg combined
US$ 20.01
US$ 21.22
US$ 28.77
